| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.1 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |